Meditor Ltd 13F annual report
Meditor Ltd is an investment fund managing more than $54.1 billion ran by Brian Desmond. There are currently 4 companies in Mr. Desmond’s portfolio. The largest investments include Exelixis Inc and Esperion Therapeutics, together worth $47.8 billion.
$54.1 billion Assets Under Management (AUM)
As of 15th July 2024, Meditor Ltd’s top holding is 1,753,000 shares of Exelixis Inc currently worth over $39.4 billion and making up 72.9% of the portfolio value.
Relative to the number of outstanding shares of Exelixis Inc, Meditor Ltd owns more than approximately 0.1% of the company.
In addition, the fund holds 3,791,300 shares of Esperion Therapeutics worth $8.42 billion, whose value grew 11.2% in the past six months.
The third-largest holding is Ishares Msci India Etf worth $3.33 billion and the next is Wisdomtree India Earnings Fund worth $2.93 billion, with 60,700 shares owned.
Currently, Meditor Ltd's portfolio is worth at least $54.1 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Meditor Ltd
The Meditor Ltd office and employees reside in Hamilton, Bermuda. According to the last 13-F report filed with the SEC, Brian Desmond serves as the Director, Meditor Group Limited at Meditor Ltd.
Recent trades
Brian Desmond disclosed a decreased stake in Exelixis Inc by 0.2%.
This leaves the value of the investment at $39.4 billion and 1,753,000 shares.
One of the smallest hedge funds
The two most similar investment funds to Meditor Ltd are Mangham Associates and Rpd Fund Management. They manage $53.9 billion and $53.9 billion respectively.
Brian Desmond investment strategy
Meditor Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 88.4% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $2.83 billion.
The complete list of Meditor Ltd trades based on 13F SEC filings
These positions were updated on July 22nd based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Exelixis Inc |
20.27%
1,753,000
|
$39,389,910,000 | 72.86% |
| Esperion Therapeutics Inc. |
No change
3,791,300
|
$8,416,686,000 | 15.57% |
| Ishares Msci India Etf |
No change
59,400
|
$3,326,400,000 | 6.15% |
| Wisdomtree India Earnings Fund |
No change
60,700
|
$2,930,596,000 | 5.42% |
| No transactions found | |||
| Showing first 500 out of 4 holdings | |||
Hedge funds similar to Meditor Ltd
- Lockerman Financial Group, Inc
- United Fire Inc
- Van Eck Associates Corp
- Smart Portfolios
- St. James Investment Advisors
- Moneda Usa, Inc
- Advisor Resource Council
- Mangham Associates
- Rpd Fund Management
- West Chester Capital Advisors, Inc
- Dekabank Deutsche Girozentrale
- Arboretum Ventures
- Glaxis Capital Management
- Alpha Square S